Author: Tom Wilemon

Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis

Nov. 16, 2022—Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis.

Study finds inherited link to appendix cancer

Nov. 11, 2022—A Vanderbilt study is the first to show inherited risk factors for appendiceal cancer.

Study reveals pathways for aggressive prostate cancer subtype

Oct. 27, 2022—Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.

Event set to make lung cancer screening more accessible

Oct. 20, 2022—Vanderbilt University Medical Center is making the lung cancer screening more convenient with weekend appointments from 8 a.m. to noon on Saturday, Nov. 12, at Vanderbilt Health One Hundred Oaks

Osterman appointed chair of mCODE executive committee

Oct. 20, 2022—Vanderbilt's Travis Osterman, DO, MS, has been appointed chair of the executive committee for the Minimal Common Data Elements (mCODE) initiative.

Vanderbilt Health Pleasant View is located just off Interstate 24 at 6536 Highway 41A in Pleasant View, Tennessee.

Vanderbilt Health Pleasant View now open

Sep. 30, 2022—The new Vanderbilt Health Pleasant View outpatient clinic offers greater convenience to primary care and specialized medical services for patients in Cheatham, Montgomery and Robertson counties.

Vanderbilt lauded for pancreatic cancer, pancreatitis care

Sep. 29, 2022—Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.

Members of the newly named MASLAB gathered for a portrait on the Medical Center Plaza. The early lung cancer detection research initiative was named in honor of the late Pierre Massion, MD.

Lung cancer detection program lands grant renewal

Sep. 15, 2022—The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.

Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial

Sep. 13, 2022—Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.

Eunyoung Choi, PhD, James Goldenring, MD, PhD, and colleagues are studying the development of cancer in the stomach and esophagus.

Grant supports research to study gastric cancer origins

Sep. 1, 2022—Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level.

Chic Aweareness ovarian cancer fundraiser moves online

Sep. 1, 2022—Chic Awearness, a fundraiser for ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC), is an online event this year from now throughout September with an in-store shopping opportunity to close out the month called Chic Week.